Skip to Main Content

Paper Details

A patient-driven clinicogenomic partnership for metastatic prostate cancer.
Cell Genom
4
2022
MPC, MPCproject, Metastatic Prostate Cancer, cell-free DNA, cfDNA, cfDNA samples, metastatic prostate cancer, mpcproject, participants, patient, patients, tumor
Author NameAffiliation
Stephanie A WankowiczUniversity of California San Francisco
Stephanie A WankowiczUniversity of California San Francisco
Alok K TewariDana-Farber Cancer Institute
Eric S LanderBroad Institute of Harvard and MIT
Eric S LanderHarvard Medical School
Eric S Lander
Eric S LanderBroad Institute of Harvard and MIT
Eric S Lander
Eric S LanderHarvard Medical School
Nikhil WagleDana-Farber Cancer Institute
Nikhil Wagle
Nikhil Wagle
Nikhil WagleBroad Institute of Harvard and MIT
Nikhil WagleDana-Farber Cancer Institute
Nikhil WagleBroad Institute of Harvard and MIT
Nikhil Wagle
Nikhil Wagle
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenBroad Institute of Harvard and MIT
Eliezer M Van AllenCenter for Cancer Genomics, Dana-Farber Cancer Institute
Eliezer M Van Allen
Eliezer M Van Allen
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenBroad Institute of Harvard and MIT
Eliezer M Van AllenCenter for Cancer Genomics, Dana-Farber Cancer Institute
Eliezer M Van Allen
Eliezer M Van Allen
  • 1 - 27

Datasets

Release 1.2